Global Avelumab Market Growth 2022-2028
- LP 4768458
- 74 Pages
- January 2022
- Pharmaceuticals
The United States Avelumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Avelumab market, reaching US$ million by the year 2028. As for the Europe Avelumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Avelumab players cover Merck, Pfizer, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Avelumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
By Usage
By Specifications
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Merkel-cell Carcinoma
Non-small Cell Lung Carcinoma (NSCLC)
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Avelumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Avelumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Avelumab by Country/Region, 2017, 2022 & 2028
2.2 Avelumab Segment by Type
2.2.1 Type I
2.2.2 Type II
2.3 Avelumab Sales by Type
2.3.1 Global Avelumab Sales Market Share by Type (2017-2022)
2.3.2 Global Avelumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Avelumab Sale Price by Type (2017-2022)
2.4 Avelumab Segment by Application
2.4.1 Merkel-cell Carcinoma
2.4.2 Non-small Cell Lung Carcinoma (NSCLC)
2.4.3 Other
2.5 Avelumab Sales by Application
2.5.1 Global Avelumab Sale Market Share by Application (2017-2022)
2.5.2 Global Avelumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Avelumab Sale Price by Application (2017-2022)
3 Global Avelumab by Company
3.1 Global Avelumab Breakdown Data by Company
3.1.1 Global Avelumab Annual Sales by Company (2020-2022)
3.1.2 Global Avelumab Sales Market Share by Company (2020-2022)
3.2 Global Avelumab Annual Revenue by Company (2020-2022)
3.2.1 Global Avelumab Revenue by Company (2020-2022)
3.2.2 Global Avelumab Revenue Market Share by Company (2020-2022)
3.3 Global Avelumab Sale Price by Company
3.4 Key Manufacturers Avelumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Avelumab Product Location Distribution
3.4.2 Players Avelumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Avelumab by Geographic Region
4.1 World Historic Avelumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Avelumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Avelumab Annual Revenue by Geographic Region
4.2 World Historic Avelumab Market Size by Country/Region (2017-2022)
4.2.1 Global Avelumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Avelumab Annual Revenue by Country/Region
4.3 Americas Avelumab Sales Growth
4.4 APAC Avelumab Sales Growth
4.5 Europe Avelumab Sales Growth
4.6 Middle East & Africa Avelumab Sales Growth
5 Americas
5.1 Americas Avelumab Sales by Country
5.1.1 Americas Avelumab Sales by Country (2017-2022)
5.1.2 Americas Avelumab Revenue by Country (2017-2022)
5.2 Americas Avelumab Sales by Type
5.3 Americas Avelumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Avelumab Sales by Region
6.1.1 APAC Avelumab Sales by Region (2017-2022)
6.1.2 APAC Avelumab Revenue by Region (2017-2022)
6.2 APAC Avelumab Sales by Type
6.3 APAC Avelumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Avelumab by Country
7.1.1 Europe Avelumab Sales by Country (2017-2022)
7.1.2 Europe Avelumab Revenue by Country (2017-2022)
7.2 Europe Avelumab Sales by Type
7.3 Europe Avelumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Avelumab by Country
8.1.1 Middle East & Africa Avelumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Avelumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Avelumab Sales by Type
8.3 Middle East & Africa Avelumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Avelumab
10.3 Manufacturing Process Analysis of Avelumab
10.4 Industry Chain Structure of Avelumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Avelumab Distributors
11.3 Avelumab Customer
12 World Forecast Review for Avelumab by Geographic Region
12.1 Global Avelumab Market Size Forecast by Region
12.1.1 Global Avelumab Forecast by Region (2023-2028)
12.1.2 Global Avelumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Avelumab Forecast by Type
12.7 Global Avelumab Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Avelumab Product Offered
13.1.3 Merck Avelumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
14 Research Findings and Conclusion
Table 1. Avelumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Avelumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Type I
Table 4. Major Players of Type I
Table 5. Global Avelumab Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Avelumab Sales Market Share by Type (2017-2022)
Table 7. Global Avelumab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Avelumab Revenue Market Share by Type (2017-2022)
Table 9. Global Avelumab Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Avelumab Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Avelumab Sales Market Share by Application (2017-2022)
Table 12. Global Avelumab Revenue by Application (2017-2022)
Table 13. Global Avelumab Revenue Market Share by Application (2017-2022)
Table 14. Global Avelumab Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Avelumab Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Avelumab Sales Market Share by Company (2020-2022)
Table 17. Global Avelumab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Avelumab Revenue Market Share by Company (2020-2022)
Table 19. Global Avelumab Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Avelumab Producing Area Distribution and Sales Area
Table 21. Players Avelumab Products Offered
Table 22. Avelumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Avelumab Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Avelumab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Avelumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Avelumab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Avelumab Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Avelumab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Avelumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Avelumab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Avelumab Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Avelumab Sales Market Share by Country (2017-2022)
Table 35. Americas Avelumab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Avelumab Revenue Market Share by Country (2017-2022)
Table 37. Americas Avelumab Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Avelumab Sales Market Share by Type (2017-2022)
Table 39. Americas Avelumab Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Avelumab Sales Market Share by Application (2017-2022)
Table 41. APAC Avelumab Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Avelumab Sales Market Share by Region (2017-2022)
Table 43. APAC Avelumab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Avelumab Revenue Market Share by Region (2017-2022)
Table 45. APAC Avelumab Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Avelumab Sales Market Share by Type (2017-2022)
Table 47. APAC Avelumab Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Avelumab Sales Market Share by Application (2017-2022)
Table 49. Europe Avelumab Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Avelumab Sales Market Share by Country (2017-2022)
Table 51. Europe Avelumab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Avelumab Revenue Market Share by Country (2017-2022)
Table 53. Europe Avelumab Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Avelumab Sales Market Share by Type (2017-2022)
Table 55. Europe Avelumab Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Avelumab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Avelumab Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Avelumab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Avelumab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Avelumab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Avelumab Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Avelumab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Avelumab Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Avelumab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Avelumab
Table 66. Key Market Challenges & Risks of Avelumab
Table 67. Key Industry Trends of Avelumab
Table 68. Avelumab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Avelumab Distributors List
Table 71. Avelumab Customer List
Table 72. Global Avelumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Avelumab Sales Market Forecast by Region
Table 74. Global Avelumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Avelumab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Avelumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Avelumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Avelumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Avelumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Avelumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Avelumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Avelumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Avelumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Avelumab Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Avelumab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Avelumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Avelumab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Avelumab Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Avelumab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Avelumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Avelumab Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Avelumab Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Avelumab Product Offered
Table 94. Merck Avelumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Pfizer Basic Information, Avelumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Avelumab Product Offered
Table 99. Pfizer Avelumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Avelumab
Figure 2. Avelumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Avelumab Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Avelumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Avelumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Type I
Figure 10. Product Picture of Type I
Figure 11. Global Avelumab Sales Market Share by Type in 2021
Figure 12. Global Avelumab Revenue Market Share by Type (2017-2022)
Figure 13. Avelumab Consumed in Merkel-cell Carcinoma
Figure 14. Global Avelumab Market: Merkel-cell Carcinoma (2017-2022) & (K Pcs)
Figure 15. Avelumab Consumed in Non-small Cell Lung Carcinoma (NSCLC)
Figure 16. Global Avelumab Market: Non-small Cell Lung Carcinoma (NSCLC) (2017-2022) & (K Pcs)
Figure 17. Avelumab Consumed in Other
Figure 18. Global Avelumab Market: Other (2017-2022) & (K Pcs)
Figure 19. Global Avelumab Sales Market Share by Application (2017-2022)
Figure 20. Global Avelumab Revenue Market Share by Application in 2021
Figure 21. Avelumab Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Avelumab Revenue Market Share by Company in 2021
Figure 23. Global Avelumab Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Avelumab Revenue Market Share by Geographic Region in 2021
Figure 25. Global Avelumab Sales Market Share by Region (2017-2022)
Figure 26. Global Avelumab Revenue Market Share by Country/Region in 2021
Figure 27. Americas Avelumab Sales 2017-2022 (K Pcs)
Figure 28. Americas Avelumab Revenue 2017-2022 ($ Millions)
Figure 29. APAC Avelumab Sales 2017-2022 (K Pcs)
Figure 30. APAC Avelumab Revenue 2017-2022 ($ Millions)
Figure 31. Europe Avelumab Sales 2017-2022 (K Pcs)
Figure 32. Europe Avelumab Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Avelumab Sales 2017-2022 (K Pcs)
Figure 34. Middle East & Africa Avelumab Revenue 2017-2022 ($ Millions)
Figure 35. Americas Avelumab Sales Market Share by Country in 2021
Figure 36. Americas Avelumab Revenue Market Share by Country in 2021
Figure 37. United States Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Avelumab Sales Market Share by Region in 2021
Figure 42. APAC Avelumab Revenue Market Share by Regions in 2021
Figure 43. China Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Avelumab Sales Market Share by Country in 2021
Figure 50. Europe Avelumab Revenue Market Share by Country in 2021
Figure 51. Germany Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Avelumab Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Avelumab Revenue Market Share by Country in 2021
Figure 58. Egypt Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Avelumab Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Avelumab in 2021
Figure 64. Manufacturing Process Analysis of Avelumab
Figure 65. Industry Chain Structure of Avelumab
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
